{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:22:08Z","timestamp":1789593728916,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1136\/bjophthalmol-2016-308617","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T03:43:32Z","timestamp":1467949412000},"page":"423-427","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy"],"prefix":"10.1136","volume":"101","author":[{"given":"Ayala","family":"Pollack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Staurenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bickol","family":"Mukesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-308617-1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000331277","article-title":"Pseudophakic cystoid macular edema","volume":"227","author":"Lobo","year":"2012","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2016-308617-2","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jcrs.2007.05.013","article-title":"Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment","volume":"33","author":"Henderson","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0886-3350(03)00582-0","article-title":"Macular alterations after small-incision cataract surgery","volume":"30","author":"Lobo","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.iae.0000249577.92800.c0","article-title":"Evaluation of costs for cystoid macular edema among patients after cataract surgery","volume":"27","author":"Schmier","year":"2007","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-308617-5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00417-010-1484-9","article-title":"Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls","volume":"249","author":"Eriksson","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308617-6","first-page":"362","article-title":"Diabetes and retinal vascular dysfunction","volume":"9","author":"Shin","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"key":"key-10.1136\/bjophthalmol-2016-308617-7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","article-title":"Nonsteroidal anti-inflammatory drugs in ophthalmology","volume":"55","author":"Kim","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308617-8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrs.2007.08.034","article-title":"Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery","volume":"34","author":"Almeida","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcrs.2007.08.030","article-title":"Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%","volume":"34","author":"Asano","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1755-3768.2009.01582.x","article-title":"Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes","volume":"88","author":"Endo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308617-11","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1167\/iovs.07-0262","article-title":"The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation","volume":"48","author":"Miyake","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-308617-12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jcrs.2011.03.052","article-title":"Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery","volume":"37","author":"Miyake","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ajo.2008.04.036","article-title":"A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients","volume":"146","author":"Wittpenn","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308617-14","unstructured":"NEVANAC [package insert]. Fort Worth, TX: Alcon Laboratories, Inc., 2011."},{"key":"key-10.1136\/bjophthalmol-2016-308617-15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","article-title":"In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac","volume":"33","author":"Walters","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2016-308617-16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1007001131987","article-title":"Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers","volume":"24","author":"Ke","year":"2000","journal-title":"Inflammation"},{"key":"key-10.1136\/bjophthalmol-2016-308617-17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IAE.0b013e3181b094e6","article-title":"Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%","volume":"29","author":"Heier","year":"2009","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-308617-18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/OPTH.S31902","article-title":"Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy","volume":"6","author":"Singh","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308617-19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","article-title":"Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography","volume":"114","author":"Kim","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308617-20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ophtha.2006.10.055","article-title":"Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema","volume":"114","author":"Krzystolik","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308617-21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/IAE.0b013e318169d04e","article-title":"A method of reporting macular edema after cataract surgery using optical coherence tomography","volume":"28","author":"Kim","year":"2008","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-308617-22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","article-title":"Diabetic macular edema: pathophysiology and novel therapeutic targets","volume":"122","author":"Das","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308617-23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","article-title":"Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review","volume":"25","author":"Gaynes","year":"2002","journal-title":"Drug Saf"},{"key":"key-10.1136\/bjophthalmol-2016-308617-24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/OPTH.S1067","article-title":"Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension","volume":"2","author":"Gaynes","year":"2008","journal-title":"Clin Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-308617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:52:56Z","timestamp":1601110376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-308617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,3,21]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/bjophthalmol-2016-308617"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308617","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}